Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

Back to Item »

Dainippon Pays Boston Biomedical $15M Up Front for Option to Phase I/II Cancer Candidate

BBI could receive $100 million in milestones if DSP takes on license for Japan and $55 million during negotiation period for U.S. and Canadian rights.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »